How do CGRP monoclonal antibodies become prescribed in terms of administration?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

How do CGRP monoclonal antibodies become prescribed in terms of administration?

The main idea is that CGRP monoclonal antibodies are given by subcutaneous injections at regular intervals, not daily pills or weekly infusions. Most of these agents are dosed monthly by subcutaneous injection, with fremanezumab offering either monthly or quarterly schedules depending on the regimen. An important exception is eptinezumab, which is given by intravenous infusion every 12 weeks. So the typical prescription pattern is subcutaneous injections at monthly or quarterly intervals, depending on the specific agent.

The main idea is that CGRP monoclonal antibodies are given by subcutaneous injections at regular intervals, not daily pills or weekly infusions. Most of these agents are dosed monthly by subcutaneous injection, with fremanezumab offering either monthly or quarterly schedules depending on the regimen. An important exception is eptinezumab, which is given by intravenous infusion every 12 weeks. So the typical prescription pattern is subcutaneous injections at monthly or quarterly intervals, depending on the specific agent.

More practice questions